| For: | Fennessy A, Doyle M, Boland A, Bourke R, O'Connor A. Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (train-IBD trial). World J Gastrointest Pharmacol Ther 2025; 16(2): 101268 [PMID: 40575360 DOI: 10.4292/wjgpt.v16.i2.101268] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v16/i2/101268.htm |
| Number | Citing Articles |
| 1 |
Muhammad Ikhmal Rosali, Dinesh Prasad V. Thanga Velu, Mohd Helmy Mokhtar, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar, Adila A. Hamid. Specificity vs. Synergy Between Single-Strain and Multi-Strain Probiotics for Ulcerative Colitis Treatment: A Review of the Literature. Biomedicines 2026; 14(6) doi: 10.3390/biomedicines14061386
|
| 2 |
Yixuan Li. Gut microbiota in the pathogenesis and treatment of inflammatory bowel disease: a critical review of mechanisms and therapeutic advances. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1738292
|
| 3 |
Junxiong Zhou, Jialu Cao, Shumin Dong, Haonan Li, Shutong Yang, Ze Yan, Chanmin Wang, Yaoshun Pei, Yian Su, Bin Wen, Honglei Zhang, Li Ma, Caihong Wang, Yufeng Fan, Yukai Jing. Probiotics in Autoimmune Disease: Strain-specific Mechanisms and Therapeutic Perspectives. Clinical Reviews in Allergy & Immunology 2026; 69(1) doi: 10.1007/s12016-026-09190-2
|
| 4 |
Xuemei Li, Qiang Yuan, Hui Huang, Li Wang. Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1695321
|